纯度:99%蛋白浓度:6.5mg/ml内毒素:<1EU/mg。 产品名称:Anti-mouse PD-L1 (B7-H1)-InVivo 抗体 产品货号:A2115 产品品牌:Selleck Selleck 动物体内抗体 现货供应 买试剂,找华雅,生物试剂专业供应商——华雅思创生物 selleck品牌代理商——买selleck抑制剂,抗体,化合物库,就来华雅思创 ...
selleck Anti-mouse CD8α-InVivo抗体 价格: 价格电议 产品详情:产品名称:selleck Anti-mouse CD8α-InVivo抗体产品货号:A2115 产品品牌:Selleck Selleck 动物体内抗体 现货供应... 包装规格:1mg、5mg 品牌:Selleck 抗体名:Anti-mouse CD8α-InVivo 保存条件:Store the undiluted solution at 4°C in the dar...
selleck品牌代理商——买selleck抑制剂,抗体,化合物库,就来华雅思创 产品介绍: Anti-mouse PD-L1 (B7-H1)-InVivo (克隆号:10F.9G2)单克隆抗体可与小鼠PD-L1(也称为B7-H1、CD274)发生反应。10F.9G2 抗体已被证明可以阻断 PD-L1 和 PD-1 之间以及 PD-L1 和 B7-1 (CD80) 之间的相互作用 ...
selleck品牌代理商——买selleck抑制剂,抗体,化合物库,就来华雅思创 产品介绍: Anti-mouse PD-L1 (B7-H1)-InVivo (克隆号:10F.9G2)单克隆抗体可与小鼠PD-L1(也称为B7-H1、CD274)发生反应。10F.9G2 抗体已被证明可以阻断 PD-L1 和 PD-1 之间以及 PD-L1 和 B7-1 (CD80) 之间的相互作用 ...
selleck品牌代理商——买selleck抑制剂,抗体,化合物库,就来华雅思创 产品介绍: Anti-mouse PD-L1 (B7-H1)-InVivo (克隆号:10F.9G2)单克隆抗体可与小鼠 PD-L1(也称为B7-H1、CD274)发生反应。10F.9G2 抗体已被证明可以阻断 PD-L1 和 PD-1 之间以及 PD-L1 和 B7-1 (CD80) 之间的相互作用 纯度: ...
Obatoclax inhibited Hepa1–6 cell proliferation and promoted apoptosis in vitro To dissect the effects of obatoclax on tumor cell viability. We firstly treated mouse HCC cell line Hepa1–6 with different concentrations of obatoclax. CCK-8 results showed that obatoclax inhibited Hepa1–6 cell...
These information supply unique proof that aggregation is elevated in mouse minds and brains after myocardial ischemia, leading to cognitive impairment resembling AD, but could be attenuated by exosomes or medication (CDN1163) interventions that oppose ER stress.How to prioritise numerous objectives is ...
Ori suppresses NLRP3-dependent peritonitis and gouty arthritis.a,bELISA of IL-1β in the serum (a) or peritoneal cavity (b) from WT orNlrp3-/-mice intraperitoneally injected with MSU crystals (1 mg/mouse) in the presence or absence of Ori (20 mg/kg). Data expressed as mean and...
Cancer expression of PD-L1 suppresses anti-tumor immunity. PD-L1 has emerged as a remarkable therapeutic target. However, the regulation of PD-L1 degradation is not understood. Here, we identify several compounds as inducers of PD-L1 degradation using a
Fexagratinib dosages of 6.25/12.5 mg·kg−1 were selected based on recent pharmacokinetics/pharmacodynamics (PK/PD) studies, indicating that these doses efficiently inhibit FGFR in mouse models (Gavine et al., 2012). 2.4 Tissue protein extraction and western blot analysis Quantification of ...